Patent intelligence · US
US 9259456
Methods and compositions for oral administration of proteins
Methods and compositions for oral administration of proteins
Patent details — US 9259456
- Jurisdiction
- US
- Status
- granted
- Grant date
- Feb 16, 2016
- Expiration
- Feb 11, 2036
- Applicant
- Oramed Pharmaceuticals Inc.
- Claims
- 45
- CPC classes
- A61K, A61K31/202, A61K31/22, A61K35/60
Quick answer
US 9259456 (Methods and compositions for oral administration of proteins) is held by Oramed Pharmaceuticals Inc.. Status: granted. Granted Feb 16, 2016. Expires Feb 11, 2036 (10 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Oramed Pharmaceuticals Inc.
- Grant date
- Expiration
- Claims
- 45
- CPC classes
- A61K, A61K31/202, A61K31/22, A61K35/60, A61K38/28, A61K38/56
More from Oramed Pharmaceuticals Inc.
Related pharmaceutical patents in our USPTO index.
-
US 11660327
Methods and compositions for oral administration of proteins
granted -
US 11395848
Methods and compositions for treating diabetes
granted -
US 10967051
Methods and compositions for treating NAFLD, hepatic steatosis, and sequelae thereof
granted -
US 10933022
Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same
granted -
US 10881714
Methods and compositions for oral administration of proteins
granted -
US 10398762
Methods and compositions for treating diabetes
granted -
US 10350162
Methods and compositions for oral administration of exenatide
granted -
US 10342764
Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same
granted
Frequently asked questions
What is US patent 9259456?
US 9259456 (Methods and compositions for oral administration of proteins) is held by Oramed Pharmaceuticals Inc.. Status: granted. Granted Feb 16, 2016. Expires Feb 11, 2036 (10 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9259456?
Oramed Pharmaceuticals Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 10 pharmaceutical patents for this assignee.
When does US 9259456 expire?
Our index shows an expiration date of Feb 11, 2036 (10 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.